Read + Share
Najjar YG, McCurry D, Lin H, Lin Y, et al. Neoadjuvant Pembrolizumab and High Dose Interferon Alfa-2b in Resectable
Regionally Advanced Melanoma. Clin Cancer Res 2021 Mar 22. pii: 1078-0432.CCR-20-4301.
PMID: 33753453
|
 |
|
Najjar YG, McCurry D, Lin H, Lin Y, et al. Neoadjuvant Pembrolizumab and High Dose Interferon Alfa-2b in Resectable
Regionally Advanced Melanoma. Clin Cancer Res 2021 Mar 22. pii: 1078-0432.CCR-20-4301.
PMID: 33753453
|
|
|
|